Medispray Laboratories Private Limited
Indian Pharmaceutical Exporter · Respiratory Specialist · $16.4M Total Trade · DGFT Verified
Medispray Laboratories Private Limited is an Indian pharmaceutical exporter with a total trade value of $16.4M across 7 products in 2 therapeutic categories. Based on 407 verified export shipments from Indian Customs (DGFT) records, Medispray Laboratories Private Limited is the #1 Indian exporter in 2 products including Citalopram, Escitalopram. Top exports include Salbutamol ($4.9M), Citalopram ($3.9M), Escitalopram ($3.9M).
Medispray Laboratories Private Limited — Export Portfolio & Destination Treemap

Who is Medispray Laboratories Private Limited? — Company Overview & Market Position
Medispray Laboratories Private Limited, incorporated on February 21, 1992, is a private Indian pharmaceutical company headquartered in Goa. The company is registered under the Corporate Identification Number (CIN) U52311GA1992PTC002801. Its authorized share capital is ₹51,000,000, with a paid-up capital of ₹510,200. The registered office is located at Plot No. 344/345, Kundaim Industrial Estate, Kundaim, Goa 403 115.
Medispray Laboratories specializes in the manufacturing and export of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. The company's product portfolio is concentrated in two therapeutic categories: Respiratory (53.0%) and CNS & Psychiatric (47.0%). Notably, Medispray holds the number one market position in Citalopram and Escitalopram, with respective market shares of 1.5% and 2.0%. The top five products—Salbutamol, Citalopram, Escitalopram, Salmeterol, and Fluticasone—account for 89.3% of the company's total export value.